Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of
    The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital China, Hong Kong
    COVID-19 Disease Burden on the High Risk Population
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Interdisciplinary Collaboration for the Management of Severe Alopecia Areata in Patients with Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Antimicrobial Stewardship in the Sub-Saharan African Region
    Release Date:
    Partner: International Society for Infectious Diseases
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology All
    Enhancing Patient-Centered Outcomes in Emergency Department Migraine Management
    Release Date:
    Partner: American College of Emergency Physicians (ACEP)
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada, USA
    ADVANCE: Global Awards for Advancing Chronic Pain Research
    Release Date:
    Partner: Eli Lilly and Company
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology United Kingdom
    New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology France, Germany, Italy, Spain, USA, United Kingdom
    Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Remote Mentoring Programs in RCC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)
    Release Date:
    Partner: The Sharing Progress in Cancer Care (SPCC)
    Review Process: Expert Review Panel
    Quality Improvement Oncology All
    Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Canada, USA
    NSCLC Oncogene Driver Considerations in Testing & Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology France, Germany